FCH/Cdc15 domain determines distinct subcellular localization of NOSTRIN  by Icking, Ann et al.
FEBS Letters 580 (2006) 223–228FCH/Cdc15 domain determines distinct subcellular localization
of NOSTRIN
Ann Icking1, Kirstin Schilling1, Anja Wiesenthal, Nils Opitz, Werner Mu¨ller-Esterl*
Institute of Biochemistry II, University of Frankfurt Medical School, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany
Received 18 November 2005; accepted 30 November 2005
Available online 12 December 2005
Edited by Peter BrzezinskiAbstract NOSTRIN, an NO synthase binding protein, belongs
to the PCH family of proteins, exposing a typical domain struc-
ture. While its SH3 domain and the C-terminal coiled-coil region
cc2 have been studied earlier, the function of the N-terminal half
comprising a Cdc15 domain with an FCH (Fes/CIP homology)
region followed by a coiled-coil stretch cc1 is unknown. Here,
we show that the FCH region is necessary and suﬃcient for
membrane association of NOSTRIN, whereas the Cdc15 domain
further speciﬁes subcellular distribution of the protein. Thus, the
FCH region and the Cdc15 domain fulﬁll complementary func-
tions in subcellular targeting of NOSTRIN.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cdc151. Introduction
The FCH region was ﬁrst described in Fes kinase and a
Cdc42-interacting protein, CIP4, hence the name Fes/CIP
homology [1]. To date, more than 100 proteins containing this
region are known which belong to either the Fps/Fes/Fer sub-
family of protein tyrosine kinases, the RhoGAP family, or the
PCH (pombe cdc15 homology) family [2,3]. PCH proteins
share a typical domain structure with an FCH region at the
very N-terminus, followed by one or two coiled-coil stretches,
and an SH3 domain at the C-terminus. Members of this family
include CIP4 [1], PSTPIP [4], pacsins/syndapins [5,6], and
Toca-1 [7] which primarily perform functions at the interface
of membranes and the cytoskeleton. The SH3 domain of many
of the PCH proteins mediates binding to several accessory pro-
teins that are required during processes such as membrane ﬁs-
sion and rearrangement of the cytoskeleton. The most
frequently described binding partners are the large GTPase
dynamin and the Arp2/3 activating protein N-WASP [5,7,8].
By contrast, the role of the FCH region is poorly understood.
Recent studies have indicated that FCH may mediate associa-
tion with microtubules for some PCH proteins, e.g., CIP4 and
Rapostlin, i.e., the rat ortholog of FBP17 (formin binding pro-
tein) [8,9]. However, in the case of Fes kinase, the FCH region
was dispensable for its localization to microtubules [10].*Corresponding author. Fax: +49 69 6301 5577.
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doi:10.1016/j.febslet.2005.11.078We have recently identiﬁed a novel PCH protein, NOSTRIN,
which associates with endothelial nitric oxide synthase (eNOS)
and regulates traﬃcking and activity of this enzyme [11,12].
NOSTRIN is found at the plasma membrane as well as at vesic-
ular and ﬁlamentous structures throughout the cytoplasm. Sim-
ilar to other proteins of the PCH family, NOSTRIN exhibits a
typical domain structure (Fig. 1A). Bymeans of its SH3 domain
NOSTRIN interacts with eNOS [12], dynamin and N-WASP
[13]. A coiled-coil region (cc2) neighboring the SH3 domain
facilitates trimerization of NOSTRIN enabling the protein to
bring together its diﬀerent binding partners in a large complex.
The N-terminal portion of NOSTRIN harbors a single FCH re-
gion, followed by a coiled-coil stretch (cc1); together, these two
regions form a typical Cdc15 domain (FCH + cc1). Here, we set
out to elucidate the role of the FCH/Cdc15 domain in subcellu-
lar targeting of NOSTRIN.2. Materials and methods
2.1. Reagents and antibodies
Methotrexate and antibodies to GFP, a-tubulin and a-actin were
from Sigma (Taufkirchen, Germany). Murine monoclonal antibody
to human NOSTRIN was generated using GST-tagged NOS-
TRIN242–506 puriﬁed from Escherichia coli (Nanotools, Teningen, Ger-
many). Phalloidin-Alexa 647 was purchased from Molecular Probes
(Eugene, USA).
2.2. Cell culture and transfection
HeLa and HEK293 cells were cultured in Dulbeccos modiﬁed Ea-
gles medium (DMEM) supplemented with 10% fetal calf serum
(FCS). Chinese hamster ovary (CHO) cells stably expressing eNOS
(CHO-eNOS) were cultured in DMEM/10% FCS containing 200 nM
methotrexate [12]. Transient transfections were performed with Nano-
fectin (PAA, Co¨lbe, Germany) for CHO-eNOS and HeLa, or Metafec-




pCMV5B-NOSTRIN-DSH3 were as described before [12,13]. Further
deletion constructs of NOSTRIN were produced by PCR using site-
speciﬁc primers. PCR products were cloned into pcDNA3.1 (Invitro-
gen, Karlsruhe, Germany) or pEGFP-N1 (Clontech, Palo Alto,
USA) and sequenced.
2.4. Confocal laser-scanning microscopy
CHO-eNOS and HeLa cells on coverslips were transiently transfec-
ted with the diﬀerent constructs as indicated. Coverslips were prepared
for confocal laser-scanning microscopy (CLSM) 20–24 h post-transfec-
tion as described before [13]. For co-staining with cytoskeletal pro-
teins, we used a stabilizing buﬀer (100 mM PIPES, pH 6.9; 1 mM
MgSO4, 2 mM EGTA) throughout the procedure.blished by Elsevier B.V. All rights reserved.
Fig. 1. Domain structure of NOSTRIN. (A) List of deletion
constructs used (FCH, Fes/CIP homology; cc, coiled-coil; Cdc15, S.
pombe Cdc15 homology domain; SH3, src homology). (B) Expression
of diﬀerent NOSTRIN constructs in HEK293 cells. Lysates of
transiently transfected HEK293 cells were analyzed by Western
blotting using anti-NOSTRIN (left panel) and anti-GFP (right panel),
respectively.
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After washing with PBS, cells were homogenized mechanically in
hypotonic buﬀer (0.25 M sucrose /1 mM EGTA/10 mM Hepes/NaOH,
pH 7.2) on ice. Nuclei and insoluble components were pelleted by cen-
trifugation (2000 · g, 4 C, 10 min) and lysed in buﬀer containing
63 mM Tris–HCl, pH 6.8, 2.5% SDS, 5% glycerol, 5% b-mercap-
toethanol, 0.005% bromophenol blue (lysis buﬀer). From the superna-
tant, cellular membranes were obtained by ultracentrifugation
(100000 · g, 4 C, 1 h; Beckman TLA-55 rotor). The membrane pellets
and the supernatant containing cytosolic proteins were resuspended in
lysis buﬀer. All fractions (100% of the pellets, 50% of the cytosol super-
natant) were analyzed by SDS–PAGE andWestern blotting using anti-
NOSTRIN, mouse anti-GFP and anti-a-actin.3. Results
3.1. Diﬀerent domains of NOSTRIN govern its subcellular
localization
We reported earlier that NOSTRIN targets to diﬀerent sub-
celluar locales including parts of the plasma membrane, vesic-
ular and/or ﬁlamentous structures throughout the cell [13],
with distribution varying to some extent depending on cell type
and expression level. To study the role of the diﬀerent domains
of NOSTRIN for its localization, we created several constructs
(Fig. 1A) where single domains were deleted (DFCH, DCdc15,
DSH3) or expressed as such (FCH, Cdc15). When transfected
into CHO-eNOS [12], HeLa or HEK 293 cells, the FCH and
Cdc15 constructs failed to be expressed. This was not unex-
pected since we had earlier encountered poor solubility of these
fragments, which may have led to their degradation (unpub-
lished results). To circumvent this problem, we created GFP
fusion proteins of these constructs (FCH–GFP and Cdc15–
GFP), which were readily expressed (Fig. 1B). Since GFP-tagged full-length NOSTRIN displayed a similar localization
as wild-type NOSTRIN [12], we were conﬁdent that GFP fu-
sion does not interfere with the subcellular distribution of
the smaller fragments, either.
When analyzed by CLSM in HeLa and CHO-eNOS cells,
each of the NOSTRIN constructs displayed a distinct localiza-
tion. Full-length NOSTRIN was found at the plasma mem-
brane, intracellular vesicles and it was partially associated
with ﬁlamentous structures (Fig. 2). The DSH3 construct was
exclusively found at small vesicular structures. Both DFCH
and DCdc15 were mainly diﬀusely distributed throughout the
cytoplasm and nucleus (Fig. 2), suggesting that the N-terminal
part of NOSTRIN may be important for the proteins mem-
brane localization. Indeed, Cdc15–GFP predominately local-
ized to the plasma membrane and vesicular structures
(Fig. 2). The FCH construct was also found at vesicular struc-
tures but was mainly absent from the plasma membrane. Over-
all, the localization of the diﬀerent constructs was similar in
HeLa and CHO-eNOS cells. Minor diﬀerences in their distri-
bution patterns among various cell types may be due to diﬀer-
ential expression of NOSTRIN binding partners. Taken
together, these ﬁndings indicate that the FCH region alone
may be suﬃcient for membrane targeting.
3.2. The FCH region mediates membrane association of
NOSTRIN
To consolidate these observations, we examined the distribu-
tion of NOSTRIN constructs by subcellular fractionation.
Applying two steps of centrifugation, we separated (1) a ‘‘hea-
vy’’ fraction containing the nucleus and cytoskeletal compo-
nents (2000 · g), (2) a membrane sediment (100000 · g), and
(3) a fraction with soluble components of the cytosol (superna-
tant of 100000 · g) [12]. Full-size NOSTRIN and NOSTRIN–
GFP partitioned equally to the heavy and membrane fraction
but were absent from the cytosol (Fig. 3). Constructs retaining
the FCH region (DSH3, Cdc15–GFP and FCH–GFP) dis-
played a similar distribution, conﬁrming that the FCH region
is suﬃcient for targeting NOSTRIN to membranes.
Accordingly, the NOSTRIN mutant lacking FCH (DFCH)
was largely absent from the membrane fraction, leaving the
majority in the cytoskeleton-bound and/or nuclear parts of
the cell. NOSTRIN lacking FCH and the following coiled-coil
stretch cc1 (DCdc15) was partially present in the cytosol frac-
tion which is in line with our previous ﬁndings that this con-
struct is easy to solubilize [12]. Of note, a fraction of the
DCdc15 mutant was still membrane-associated, which may
be due to interaction of the construct via membrane-bound
partners of its SH3 domain. Thus, our subcellular fraction-
ation studies conﬁrm that the FCH region of NOSTRIN is
both suﬃcient and necessary for the proteins association with
membranes.
3.3. Distinct subcellular distribution of NOSTRIN depends on
the Cdc15 domain
To ﬁnd out how FCH and Cdc15 contribute to distribution
of NOSTRIN to various subcellular membranes, full-size
NOSTRIN was co-expressed with FCH or Cdc15 constructs.
Since both of these fragments do not show signiﬁcant oligo-
merization with full-size NOSTRIN [13] they should not be
inﬂuenced in their localization by its co-expression. Using a
NOSTRIN antibody speciﬁc for the C-terminus of NOSTRIN,
we were able to selectively detect the full-size protein, without
Fig. 2. Distinct localization of NOSTRIN deletion constructs. CHO-eNOS (top) and HeLa cells (bottom) were transiently transfected with full-size
NOSTRIN, FCH–GFP, Cdc15–GFP DSH3, DFCH, or DCdc15. Untagged constructs were detected by indirect immunoﬂuorescence using anti-
NOSTRIN.
A. Icking et al. / FEBS Letters 580 (2006) 223–228 225
Fig. 3. Subcellular distribution of NOSTRIN deletion constructs.
CHO-eNOS cells were transiently transfected with NOSTRIN con-
structs as indicated. After mechanical disruption, cells were centrifuged
at 2000 · g to pellet the insoluble and nuclear (‘‘heavy’’) fraction (1),
followed by ultracentrifugation at 100000 · g to obtain the membrane
fraction (2). The supernatant contains soluble components of the
cytosol (3). All fractions (100% of fractions 1 and 2, 50% of fraction 3)
were analyzed by Western blotting using anti-GFP or anti-NOSTRIN.
Anti-a-actin was used as control.
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structs. Full-size NOSTRIN displayed substantial co-localiza-
tion with both FCH–GFP and Cdc15–GFP (Fig. 4A). The
FCH construct was predominantly found in the perinuclear re-
gion but was absent from NOSTRIN-positive locales at the
plasma membrane. The Cdc15 construct, on the other hand,
extensively overlapped with full-size NOSTRIN including
more peripheral vesicular structures and the plasma mem-
brane. These ﬁndings indicate that the Cdc15 domain directs
the subcellular localization of NOSTRIN. The C-terminal half
of the protein including SH3 and binding partners thereof may
ﬁne-tune the proteins ﬁnal destination within cells.3.4. NOSTRIN partially associates with actin but not with
microtubules
Since the FCH region was suggested to mediate association
with microtubules for some proteins [8,9], we analyzed if NOS-
TRIN overlaps with microtubules. However, using CHO-
eNOS cells expressing NOSTRIN we clearly do not observe
co-localization with the microtubule network (Fig. 4B, upper).
Furthermore, treatment with colchicine to destabilize microtu-
bules did not signiﬁcantly change the localization of NOS-
TRIN (not shown). In contrast, cytochalasin D-induced
destabilization of the actin cytoskeleton completely altered
the localization of NOSTRIN [13]. Accordingly, NOSTRIN
partially localized to structures also containing phalloidin-la-
beled actin (Fig. 4B, lower). NOSTRIN appears to speciﬁcally
interact with selected actin structures, excluding stress ﬁbers in
CHO-eNOS cells. Finally we also assessed if NOSTRIN may
co-localize with intermediate ﬁlaments, however, in CHO-
eNOS and HeLa cells there was no overlap of NOSTRIN
and vimentin (not shown).4. Discussion
As a prototypic member of the PCH family of proteins,
NOSTRIN features a characteristic domain structure. We
have previously assessed the function of the SH3 domain
which mediates interaction with multiple binding partners like
eNOS [12], dynamin, or N-WASP [13]. The C-terminal coiled-
coil domain (cc2), on the other hand, facilitates oligomeriza-
tion of NOSTRIN, allowing it to act as an adaptor protein
[13]. So far, the function of the N-terminal half of NOSTRIN
has remained unknown.
Studies on the function of the FCH region in other proteins
have indicated a role in association with microtubules, but they
have not led to unisonous results. In case of the PCH protein
CIP4, the full-size protein but not a mutant lacking the FCH
region was able to bind to microtubules in vitro [8]. Further-
more, other PCH proteins such as Rapostlin and CIP4 have
been shown to co-localize with microtubules in cultured cells
[8,9]. However, for the receptor tyrosine kinase Fes, which is
crucially involved in formation of the microtubule network,
the FCH region is dispensable for microtubule binding
in vivo, and only required for interaction with soluble tubulin
in vitro [10,14,15]. For NOSTRIN, we were not able to detect
overlap with microtubules in CHO-eNOS or HeLa cells. Fur-
ther investigation revealed that NOSTRIN partially overlaps
with actin-containing structures. This is well in accordance with
our previous observations that the subcellular localization of
NOSTRIN is markedly altered when the actin cytoskeleton is
depolymerized, and that NOSTRIN recruits N-WASP to phal-
loidinpositive structures [13]. In human umbilical vein endothe-
lial cells (HUVEC), NOSTRIN partially co-localizes with stress
ﬁbers (K.S., unpublished observations). Other PCH family pro-
teins also act on the actin cytoskeleton, e.g., PSTPIP2 induces
actin bundling into long thick ﬁlaments [16]. This process might
involve the coiled-coil domain of PSTPIP2 which contains se-
quences similar to those found in actin-binding domains [17].
Syndapins localize to areas of actin polymerization and turn-
over but do not co-localize with stable F-actin stress ﬁbers
[18]. How NOSTRIN achieves association with a certain subset
of actin-containing structures and what function it performs at
actin ﬁlaments remains so far unknown.
Fig. 4. The Cdc15 domain determines subcellular targeting of NOSTRIN. (A) CHO-eNOS cells were transiently co-transfected with full-size
NOSTRIN and GFP-tagged FCH or Cdc15. The full-length protein was speciﬁcally detected by a monoclonal antibody recognizing an epitope
C-terminal of the Cdc15 domain. (B) CHO-eNOS cells transiently transfected with full-length NOSTRIN were labeled for microtubules using anti-
a-tubulin, and for actin ﬁlaments using phalloidin. NOSTRIN + tubulin (upper panels) and NOSTRIN + actin (lower panels) are shown separately.
Arrowheads indicate co-localization of actin and NOSTRIN.
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which diﬀers from the former by the presence of an extra
coiled-coil region (cc1) at its C-terminus, have diﬀerential
eﬀects on NOSTRIN localization. While the FCH region isnecessary and suﬃcient for association of NOSTRIN with
membranes, the extended Cdc15 domain appears to direct
the protein to diﬀerent subcellular compartments. This conclu-
sion is consistent with a recent study on the PCH member
228 A. Icking et al. / FEBS Letters 580 (2006) 223–228FBP17 demonstrating that its FCH region functions in mem-
brane targeting of the protein. Furthermore, the authors sug-
gested that the Cdc15 domain of FBP17 may be involved in
membrane deformation [19], similar to the BAR domain [20],
and that overexpression of FBP17 induces formation of tubu-
lar membrane structures in an FCH dependent manner [19]. In
this context, it seems worth mentioning that we have recently
identiﬁed an N-terminally truncated isoform of NOSTRIN,
generated by alternative splicing, which lacks nearly the entire
FCH region at its N-terminus (Mookerjee et al., manuscript in
preparation). Future studies addressing the function of full-
length NOSTRIN vs. its truncated isoform may shed new light
on the biological role(s) of FCH/Cdc15 domains.Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.febslet.2005.11.078.References
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